Page last updated: 2024-08-23

fosinopril and Obesity

fosinopril has been researched along with Obesity in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashcheulova, T; Demydenko, G; Gerasimchuk, N; Kochubiei, O; Rezunenko, Y	1
Drozd, VIu; Haĭdychuk, VS; Khukhlina, OS; Kosar, LIu; Mandryk, OIe	1
Gapon, LI; Pliusnin, AV; Popova, SN; Veber, EE; Vershinina, AM	1
Galimany, R; Higueruelo, S; Pastor, C; Romero, R; Vaquero, M	1
Aguilar-Salinas, CA; Arellano, SA; Gómez-Pérez, FJ; Guillén-Pineda, LE; Magos, GA; Rodriguez, R; Villanueva-Sanchez, O	1

Trials

1 trial(s) available for fosinopril and Obesity

Article	Year
[Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia]. Terapevticheskii arkhiv, 2005, Volume: 77, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Male; Metoprolol; Middle Aged; Obesity	2005

Article

Year

[Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia].

Terapevticheskii arkhiv, 2005, Volume: 77, Issue:4

Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Fosinopril; Humans; Hypercholesterolemia; Hypertension; Male; Metoprolol; Middle Aged; Obesity

2005

Other Studies

4 other study(ies) available for fosinopril and Obesity

Article	Year
PATHOGENETIC ADVANCES OF FOSINOPRIL SODIUM WITH HYDROCHLOROTHIAZIDE IN OBESE HYPERTENSIVE PATIENTS. Georgian medical news, 2017, Issue:271 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Case-Control Studies; Dinoprost; Diuretics; Drug Therapy, Combination; Endothelium, Vascular; Essential Hypertension; Female; Fosinopril; Humans; Hydrochlorothiazide; Male; Middle Aged; Nitric Oxide Synthase Type II; Obesity; Overweight; Receptors, Tumor Necrosis Factor, Type I; Tumor Necrosis Factor-alpha	2017
[The use of complex tools ezetimibe, hepadyfu fosinopril and correction of blood pressure and endothelial dysfunction in patients with nonalcoholic steatohepatitis and essential hypertension stage II]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2014, Volume: 67, Issue:2 Pt 2 Topics: Adenine; Anticholesteremic Agents; Azetidines; Carnitine; Drug Combinations; Endothelium, Vascular; Essential Hypertension; Ezetimibe; Fosinopril; Humans; Hypertension; Non-alcoholic Fatty Liver Disease; Obesity; Vascular Diseases	2014
Fosinopril ameliorates exogenous cholesterol-induced incipient glomerular lesions in obese Zucker rats. Effects on eicosanoid secretion. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cholesterol; Cholesterol, Dietary; Eicosanoids; Fosinopril; Kidney Glomerulus; Obesity; Proteinuria; Rats; Rats, Zucker	1998
Effects of omapatrilat on blood pressure and insulin sensitivity in an animal model of insulin resistance. Blood pressure, 2001, Volume: 10, Issue:3 Topics: Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Fosinopril; Glucose Tolerance Test; Insulin; Insulin Resistance; Male; Models, Animal; Obesity; Pyridines; Rats; Rats, Zucker; Thiazepines; Triglycerides	2001